Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics

Valentina Caputo, Salvatore Gallina, Maria Ferraro, Mark Gjomarkaj, Caterina Di Sano, Elisabetta Pace, Andreina Bruno, Andreina Bruno, Caterina Di Sano

Risultato della ricerca: Article

12 Citazioni (Scopus)

Abstract

Background: Reduced innate immunity responses as well as reduced T regulatory activities characterise bronchial asthma. Objectives: In this study the effect of budesonide on the expression of TLR4 and TLR2 in T regulatory lymphocyte sub-population was assessed. Methods: TLR4 and TLR2 expression in total peripheral blood mononuclear cells (PBMC), in CD4+/CD25+ and in CD4+/CD25- was evaluated, by flow cytometric analysis, in mild intermittent asthmatics (n = 14) and in controls (n = 11). The in vitro effects of budesonide in modulating: TLR4 and TLR2 expression in controls and in asthmatics; IL-10 expression and cytokine release (IL-6 and TNF-α selected by a multiplex assay) in asthmatics were also explored. Results: TLR4 and TLR2 were reduced in total PBMC from asthmatics in comparison to PBMC from controls. CD4+CD25+ cells expressed at higher extent TLR2 and TLR4 in comparison to CD4+CD25- cells. Budesonide was able to increase the expression of TLR4, TLR2 and IL-10 in CD4+/CD25highly+ cells from asthmatics. TLR4 ligand, LPS induced Foxp3 expression. Budesonide was also able to reduce the release of IL-6 and TNF-α by PBMC of asthmatics. Conclusions: Budesonide potentiates the activity of Treg by increasing TLR4, TLR2 and IL-10 expression. This event is associated to the decreased release of IL-6 and TNF-α in PBMC treated with budesonide. These findings shed light on new mechanisms by which corticosteroids, drugs widely used for the clinical management of bronchial asthma, control T lymphocyte activation.
Lingua originaleEnglish
pagine (da-a)93-100
Numero di pagine8
RivistaPULMONARY PHARMACOLOGY & THERAPEUTICS
Volume32
Stato di pubblicazionePublished - 2015

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint Entra nei temi di ricerca di 'Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics'. Insieme formano una fingerprint unica.

  • Cita questo

    Caputo, V., Gallina, S., Ferraro, M., Gjomarkaj, M., Di Sano, C., Pace, E., Bruno, A., Bruno, A., & Di Sano, C. (2015). Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics. PULMONARY PHARMACOLOGY & THERAPEUTICS, 32, 93-100.